Opinion/decision on a Paediatric investigation plan (PIP): Recombinant human A disintegrin and metalloprotease with thrombospind type-1 motifs 13, decision type: , therapeutic area: , PIP number: P/0489/2022

Opinion/decision on a Paediatric investigation plan (PIP): Kisplyx,Lenvatinib, decision type: , therapeutic area: , PIP number: P/0528/2022

Opinion/decision on a Paediatric investigation plan (PIP): Kyntheum,brodalumab, decision type: , therapeutic area: , PIP number: P/0490/2022

Opinion/decision on a Paediatric investigation plan (PIP): Posoleucel, decision type: , therapeutic area: , PIP number: P/0533/2022

Opinion/decision on a Paediatric investigation plan (PIP): Live, attenuated, dengue virus, serotype 1 (DENV1),Live, attenuated, chimeric dengue virus, serotype 2 (DENV2),Live, attenuated, dengue virus, serotype 3 (DENV3),Live, attenuated, dengue virus, serotype 4 (DENV4), decision type: , therapeutic area: , PIP number: P/0521/2022

Opinion/decision on a Paediatric investigation plan (PIP): Manganese chloride tetrahydrate, decision type: , therapeutic area: , PIP number: P/0498/2022

Opinion/decision on a Paediatric investigation plan (PIP): Depemokimab, decision type: , therapeutic area: , PIP number: P/0543/2022

Opinion/decision on a Paediatric investigation plan (PIP): Enzastaurin (hydrochloride), decision type: , therapeutic area: , PIP number: P/0544/2022

Opinion/decision on a Paediatric investigation plan (PIP): dolutegravir,HIV-1 Maturation Inhibitor (GSK3640254), decision type: , therapeutic area: , PIP number: P/0523/2022

Opinion/decision on a Paediatric investigation plan (PIP): Constella,linaclotide, decision type: , therapeutic area: , PIP number: P/0529/2022